Risk of Major Cardiovascular Events in Patients With Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study
J Eur Acad Dermatol Venereol, 2020.
Rungapiromnan W, Mason KJ, Lunt M, McElhone K, Burden AD, Rutter MK, Warren RB, Griffiths CEM, Ashcroft DM; BADBIR Study Group.
Read publication: J Eur Acad Dermatol Venereol
Related
Effectiveness and survival of methotrexate versus adalimumab in patients with moderate-to-severe pso...
Atopic Polygenic Risk Score Is Associated with Paradoxical Eczema Developing in Patients with Psoria...
Effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for pa...
0 Comments